Unrelated donor marrow transplantation in children

Blood

Volumn 86, Issue 8, 1995, Pages 3247-3256

  Balduzzi, Adriana ^a   Gooley, Ted ^a   Anasetti, Claudio ^a   Sanders, Jean E ^a   Martin, Paul J ^a   Petersdorf, Effie W ^a   Appelbaum, Frederick R ^a   Buckner, C Dean ^a   Matthews, Dana ^a   Storb, Rainer ^a   Sullivan, Keith M ^a   Hansen, John A ^a  

^a FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; PRIORITY JOURNAL; RELAPSE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 20244384398     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.8.3247.bloodjournal8683247     Document Type: Article

References (60)

1. Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N Engl J Med 292:832, 1975
2. Armitage JO: Bone marrow transplantation. N Engl J Med 330:827, 1994
3. Brochstein JA, Kernan NA, Groshen S, Cirrincione C, Shank B, Emanuel D, Laver J, O'Reilly RJ: Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med 317:1618, 1987
4. Sanders JE, Thomas ED, Buckner CD, Doney K: Marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 70:324, 1987
5. Dopfer R, Henze G, Bender-Gotze C, Ebell W, Ehninger G, Friedrich W, Gadner H, Klingebiel T, Peters C, Riehm H, Suttorp M, Schmid H, Schmitz N, Siegert W, Stollmann-Gibbels B, Hartmann R, Niethammer D: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM-and CoALL-protocols: Results of the German Cooperative Study. Blood 78:2780, 1991
6. Chessells JM, Bailey C, Wheeler K, Richards SM: Bone marrow transplantation for high-risk childhood lymphoblastic leukemia in first remission: Experience in MRC UKALL X. Lancet 340:565, 1992
7. Clift RA, Thomas ED, Appelbaum FR: Treatment of chronic myeloid leukemia by marrow transplantation. Blood 82:1954, 1993
8. Michel G, Gluckman E, Blaise D, Esperou-Bourdeau H, Vernant JP, Kuentz M, Bordigoni P, Milpied N, Rubie H, Thuret I, Troussard X, Frappaz D, Herve P, Plouvier E, Gratecos N, Bernaudin F, Lioure B, Bergeron C, Jouet JP, Gardembas-Pain M, Belanger C, Gouvernat J, Perrimond H, Maraninchi D: Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: A report from the Groupe d'Etude des Greffes de Moelle Osseuse. J Clin Oncol 10:1865, 1992
9. Guinan EC, Tarbell NJ, Tantravahi R, Weinstein HJ: Bone marrow transplantation for children with myelodysplastic syndromes. Blood 73:619, 1989
10. Sanders JE, Storb R, Anasetti C, Deeg HJ, Doney K, Sullivan KM, Witherspoon RP, Hansen J: Marrow transplant experience for children with severe aplastic anemia. Am J Pediatr Hematol Oncol 16:43, 1994
11. Sanders JE, Buckner CD, Thomas ED, Fleisher R, Sullivan KM, Appelbaum FA, Storb R: Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Blood 71:1144, 1988
12. Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER: Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 303:565, 1980
13. Hansen JA, Clift RA, Mickelson EM, Nisperos BN, Thomas ED: Marrow transplantation from donors other than HLA identical siblings. Hum Immunol 1:31, 1981
14. Beatty PG, Clift RA, Mickelson EM, Nisperos BB, Flournoy N, Martin PJ, Sanders JE, Stewart P, Buckner CD, Storb R, Thomas ED, Hansen JA: Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313:765, 1985
15. Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA, Gottschall JL, Oldham K, Anderson T, Camilla B, Menitove J: Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 322:485, 1990
16. Beatty PG, Hansen JA, Longton GM, Thomas ED, Sanders JE, Martin PJ, Bearman SI, Anasetti C, Petersdorf EW, Mickelson EM, Pepe MS, Appelbaum FR, Buckner CD, Clift RA, Petersen FB, Stewart PS, Storb RF, Sullivan KM, Tesler MC, Witherspoon RP: Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 51:443, 1991
17. McCullough J, Hansen J, Perkins H, Stroneck D, Bartsch G: The National Marrow Donor Program: How it works, accomplishments to date. Oncology 3:63, 1989
18. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullogh J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroncek D, Thomas ED, Blume KG: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593, 1993
19. Anasetti C, Etzioni R, Petersdorf EW, Martin PJ, Hansen JA: Marrow transplantation from unrelated volunteer donors. Annu Rev Med 46:169, 1995
20. Casper J, Camitta B, Truitt R, Baxter-Lowe, LA, Bunin N, Lewton C, Murray K, Hunter J, Piatryga D, Garbrecht F, Keever Taylor C, Drobyski W, Horowitz M, Flomenberg N, Ash R: Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 85:2354, 1995
21. Garnis AS, Haake R, McGlave R, Ramsay NK: Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children. J Clin Oncol 11:834, 1993
22. Hansen JA, Petersdorf EW, Choo SY, Martin PJ, Anasetti C: Marrow transplants from HLA partially matched relative and unrelated donors. Bone Marrow Transplant (in press)
23. Beatty PG, Anasetti C, Hansen JA, Longton GM, Sanders JE, Martin PJ, Mickelson EM, Choo SY, Petersdorf EW, Pepe MS, Appelbaum FR, Bearman SI, Buckner CD, Clift RA, Petersen FB, Singer J, Stewart PS, Storb RF, Sullivan KM, Tesler MC, Witherspoon RP, Thomas ED: Marrow transplantation from unrelated donors for treatment of hematologic malignancies: Effect of mismatching for one HLA locus. Blood 81:249, 1993
24. Storb R, Deeg J, Pepe M, Appelbaum F, Anasetti C, Beatty P, Bensinger W, Berenson R, Buckner CD, Clift R, Doney K, Longton G, Hansen J, Hill R, Loughran T, Martin P, Singer J, Sanders J, Stewart P, Sullivan K, Witherspoon R, Thomas ED: Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial. Blood 73:1729, 1989
25. Hansen JA, Mickelson EM, Choo SY, Petersdorf EW, Anasetti C, Martin PJ, Thomas ED: Clinical bone marrow transplantation: donor selection and recipient monitoring, in Rose NR, De Macario EC, Fahey JL, Friedman H, Penn GM (eds): Manual of Clinical Laboratory Immunology (ed 4). Washington, DC, American Society for Microbiology, 1992, p 850
26. Dupont B, Yang SY: Histocompatibility, in Forman SJ, Blume KJ, Thomas ED (eds): Bone Marrow Transplantation. Boston, MA, Blackwell, 1994, p 26
27. Petersdorf EW, Smith AG, Mickelson EM, Martin PJ, Hansen JA: Ten HLA-DR4 alleles defined by sequence polymorphism within the DRBl first domain. Immunogenetics 33:267, 1991
28. Durnam DM, Anders KR, Fisher L, O'Quigley J, Bryant EM, Thomas ED: Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood 74:2220, 1989
29. Blazer BR, Orr HT, Arthur DC, Kersey JH, Filipovich AH: Restriction fragment length polymorphism as markers of engraftment in allogeneic marrow transplantation. Blood 66:1436, 1985
30. Ugozzoli L, Yam P, Petz LD, Ferrara GB, Champlin RE, Forman SJ, Koyal D, Wallace RB: Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood 77:1607, 1991
31. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Shubert MM, Atkinson K, Thomas ED: Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 57:267, 1981
32. Doney KC, Weiden PL Storb R, Thomas ED: Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol 11:1, 1981
33. Anasetti C, Martin PJ, Storb R, Appelbaum FR, Beatty PG, Davis J, Doney K, Hill HF, Stewart P, Sullivan KM, Witherspoon RP, Thomas ED, Hansen JA: Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody. Transplantation 54:844, 1992
34. Anasetti C, Hansen JA, Waldmann TA, Appelbaum FR, Davis J, Deeg J, Doney K, Martin PJ, Nash R, Storb R, Sullivan KM, Witherspoon RP, Binger MH, Chizzonite R, Hakimi J, Mould D, Satoh H, Light S: Treatment of acute graft-versus-host disease with humanized anti-Tac: An antibody that binds to the interleukin-2 receptor. Blood 84:1320, 1994
35. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, Erickson K, Flowers M, Hansen J, Loughran T, Matthews D, Petersdorf E, Radich J, Riddell S, Rovira D, Sanders J, Schuening F, Siadak M, Storb R, Witherspoon RP: Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 28:250, 1991
36. Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR: The measurement of performance in childhood cancer patients. Cancer 60:1651, 1987
37. Kamofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutics in cancer, in MacLoed CM (ed): Evaluation of Chemotherapeutic Agents. New York, NY, Columbia, 1949, p 191
38. Kaplan EL, Meier P: Non-parametric estimation for incomplete observations. J Am Stat Assoc 53:547, 1958
39. Pepe MS, Longton G, Pettinger M, Mori M, Fisher LD, Storb R: Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: Motivation for and description of new methods. Br J Haematol 83:602, 1993
40. Pepe MS, Longton G, Thornquist M: A qualifier Q for the survival function to describe the prevalence of a transient condition. Stat Med 10:413, 1991
41. Kalbfleish JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
42. Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D, Riehm H: Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM Group. Blood 78:1166, 1991
43. Bleyer WA, Sather H, Hammond D: Prognosis and treatment after relapse of acute lymphoblastic leukemia and non-Hodgkin's lymphoma: 1985. A report from the Childrens Cancer Study Group. Cancer 58:590, 1986
44. Rivera GK, Buchanan G, Boyett JM, Camitta B, Ochs J, Kalwinsky D, Amylon M, Vietti T, Crist WM: Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse: A Pediatric Oncology Group study. N Engl J Med 315:273, 1986
45. Sanders JE, Doney KC, Hill R, Martin P, Buckner CD, Appelbaum FR, Bensinger WI, Petersen FB, Berenson R, Sullivan KM, Storb R, Thomas ED: Autologous marrow transplant experience for acute lymphoblastic leukemia, in Dicke KA, Spitzer G, Jagannath S, Evinger-Hodges MJ (eds): Autologous Bone Marrow Transplantation: Proceedings of the Fourth International Symposium. Houston, TX, 1989, p 145
46. Herve P, Labopin M, Plouvier E, Palut P, Tiberghien P, Gorin NC: Autologous bone marrow transplantation for childhood acute myeloid leukemia-A European survey. Bone Marrow Transplant 8:76, 1991 (suppl 1)
47. Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED, the Seattle Marrow Transplant Team: Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304:1529, 1981
48. Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L, Buckner CD, Anasetti C, Appelbaum FR, Badger C, Beatty P, Bensinger W, Berenson R, Bigelow C, Cheever MA, Clift R, Deeg HJ, Doney K, Greenberg P, Hansen JA, Hill R, Loughran T, Martin P, Neiman P, Petersen FB, Sanders J, Singer J, Stewart P, Thomas ED: Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73:1720, 1989
49. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringdén O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75:555, 1990
50. Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA, Ringdén O, Veum Stone JA, Bortin MM: Identical-twin bone marrow transplants for leukemia. Ann Intern Med 120:646, 1994
51. Kernan NA, Bordignon C, Heller G, Cunningham I, Castro-Malaspina H, Shank B, Flomenberg N, Burns J, Yang SY, Black P, Collins NH, O'Reilly R: Graft failure after T-cell-epleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood 74:2227, 1989
52. Ash RC, Horowitz MM, Gale RP, van Bekkum DW, Casper JT, Gordon-Smith EC, Henslee PJ, Kolb H-J, Lowenberg B, Masaoka T, McGlave PB, Rimm AA, Ringdén O, van Rood JJ, Sondel PM, Vowels MR, Bortin MM: Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant 7:443, 1991
53. Martin PJ, Kernan NA: T-cell depletion for the prevention of graft-versus-host disease, in Burakoff SJ, Deeg HJ, Ferrara J, Atkinson K (eds): Graft-Versus-Host Disease: Immunology, Pathophysiology, and Treatment. New York, NY, Marcel Dekker, 1990, p 371
54. Phillips GL, Barnett MJ, Brain MC, Chan KW, Huebsch LB, Klingemann H-G, Meharchand J, Reece DE, Rybka WB, Shepherd JD, Spinelli JJ, Walker IR, Messner HA: Allogeneic bone marrow transplantation using unrelated donors: A pilot study of the Canadian Bone Marrow Transplant Group. Bone Marrow Transplant 8:477, 1991
55. Atkinson K, Dodds AJ, Concannon AJ, Milliken S, Downs K, Marshall G, Wilson F, Staniforth D: Unrelated volunteer bone marrow transplantation: Initial experience at St Vincent's Hospital, Sydney. Aus N Z J Med 23:450, 1993
56. Bearman SI, Mori M, Beatty PG, Meyer WG, Buckner CD, Petersen FB, Sanders JE, Anasetti C, Martin P, Appelbaum FR, Hansen JA: Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors. Bone Marrow Transplant 13:31, 1994
57. Chao NJ, Schmidt GM, Niland JC, Amylon MD, Dagis AC, Long GD, Nademanee AE, Negrin RS, O'Donnell MR, Parker PM, Smith EP, Snyder DS, Stein AS, Wong RM, Blume KG, Forman SJ: Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease. N Eng J Med 329:1225, 1993
58. Storb R, Raff RF, Appelbaum FR, Deeg HJ, Fitzsimmons W, Graham TC, Pepe M, Pettinger M, Sale G, van der Jagt R, Schuening FG: FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors. Transplantation 56:800, 1993
59. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD, Clift R, Doney K, Martin PJ, Mickelson E, Nisperos B, O'Quigley J, Ramberg R, Sanders JE, Stewart P, Storb R, Sullivan KM, Witherspoon RP, Thomas ED, Hansen JA: Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 320:197, 1989
60. Anasetti C, Beatty PG, Storb R, Martin PJ, Mori M, Sanders JE, Thomas ED, Hansen JA: Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 29:79, 1990